Association between coronary artery calcification and left ventricular diastolic dysfunction in elderly people

Heart and Vessels

Volumn 31, Issue 4, 2016, Pages 499-507

  Osawa, Kazuhiro ^a   Miyoshi, Toru ^a   Oe, Hiroki ^b   Sato, Shuhei ^a   Nakamura, Kazufumi ^a   Kohno, Kunihisa ^a   Morita, Hiroshi ^a   Kanazawa, Susumu ^a   Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Computed tomography; Coronary artery calcification; Heart failure; Left ventricular diastolic dysfunction

Indexed keywords

AGED; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; COMPLICATION; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; DIASTOLE; EPIDEMIOLOGY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; INCIDENCE; JAPAN; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; ODDS RATIO; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; VASCULAR CALCIFICATION;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR CALCIFICATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84922700078     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-015-0645-5     Document Type: Article

References (44)

1. Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, Guerci AD, Lima JA, Rader DJ, Rubin GD, Shaw LJ, Wiegers SE (2006) Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging. Counc Clin Cardiol Circ 114(16):1761–1791
2. Raggi P, Cooil B, Shaw LJ, Aboulhson J, Takasu J, Budoff M, Callister TQ (2003) Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol 92(7):827–829
3. Wayhs R, Zelinger A, Raggi P (2002) High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 39(2):225–230
4. Vliegenthart R, Oudkerk M, Hofman A, Oei HH, van Dijck W, van Rooij FJ, Witteman JC (2005) Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 112(4):572–577
5. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P (2010) Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303(16):1610–1616
6. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC (2004) Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291(2):210–215
7. Elias-Smale SE, Proenca RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, Steyerberg EW, Hofman A, Oudkerk M, Witteman JC (2010) Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol 56(17):1407–1414
8. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O’Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA (2008) Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358(13):1336–1345
9. Kalsch H, Lehmann N, Mohlenkamp S, Neumann T, Slomiany U, Schmermund A, Stang A, Moebus S, Bauer M, Mann K, Jockel KH, Erbel R (2010) Association of coronary artery calcium and congestive heart failure in the general population: results of the Heinz Nixdorf Recall study. Clin Res Cardiol 99(3):175–182
10. Leening MJ, Elias-Smale SE, Kavousi M, Felix JF, Deckers JW, Vliegenthart R, Oudkerk M, Hofman A, Steyerberg EW, Stricker BH, Witteman JC (2012) Coronary calcification and the risk of heart failure in the elderly: the Rotterdam Study. JACC Cardiovasc Imaging 5(9):874–880
11. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355(3):251–259
12. Lam CS, Donal E, Kraigher-Krainer E, Vasan RS (2011) Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 13(1):18–28
13. Setoguchi M, Hashimoto Y, Sasaoka T, Ashikaga T, Isobe M (2014) Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction. Heart Vessels. doi:10.1007/s00380-014-0532-5
14. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161(7):996–1002
15. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348(20):2007–2018
16. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D (1999) Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33(7):1948–1955
17. Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure–—abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350(19):1953–1959
18. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15(4):827–832
19. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society Of Cardiology. Eur Heart J 28(20):2539–2550
20. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 18(12):1440–1463
21. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10(2):165–193
22. Alessandri N, Di Matteo A, Rondoni G, Petrassi M, Tufani F, Ferrari R, Laghi A (2009) Heart imaging: the accuracy of the 64-MSCT in the detection of coronary artery disease. Eur Rev Med Pharmacol Sci 13(3):163–171
23. Bastarrika G, Ramos-Duran L, Rosenblum MA, Kang DK, Rowe GW, Schoepf UJ (2010) Adenosine-stress dynamic myocardial CT perfusion imaging: initial clinical experience. Invest Radiol 45(6):306–313
24. Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF Jr, Gheorghiade M (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114(5):397–403
25. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359(23):2456–2467
26. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362(9386):777–781
27. Schmermund A, Mohlenkamp S, Berenbein S, Pump H, Moebus S, Roggenbuck U, Stang A, Seibel R, Gronemeyer D, Jockel KH, Erbel R (2006) Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. Atherosclerosis 185(1):177–182
28. Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, Rana JS, Orakzai R, Hayes SW, Friedman JD, Thomson LE, Polk D, Min J, Budoff MJ, Berman DS (2011) Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol 57(15):1622–1632
29. Ramadan MM, Mahfouz EM, Gomaa GF, El-Diasty TA, Alldawi L, Ikrar T, Limin D, Kodama M, Aizawa Y (2008) Evaluation of coronary calcium score by multi detector computed tomography in relation to endothelial function and inflammatory markers in asymptomatic individuals. Circ J 72(5):778–785
30. Odink AE, van der Lugt A, Hofman A, Hunink MG, Breteler MM, Krestin GP, Witteman JC (2007) Association between calcification in the coronary arteries, aortic arch and carotid arteries: the Rotterdam study. Atherosclerosis 193(2):408–413
31. Abhayaratna WP, Srikusalanukul W, Budge MM (2008) Aortic stiffness for the detection of preclinical left ventricular diastolic dysfunction: pulse wave velocity versus pulse pressure. J Hypertens 26(4):758–764
32. Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T (2004) Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart 90(1):37–43
33. Abhayaratna WP, Barnes ME, O’Rourke MF, Gersh BJ, Seward JB, Miyasaka Y, Bailey KR, Tsang TS (2006) Relation of arterial stiffness to left ventricular diastolic function and cardiovascular risk prediction in patients > or = 65 years of age. Am J Cardiol 98(10):1387–1392
34. Masugata H, Senda S, Yoshikawa K, Yoshihara Y, Daikuhara H, Ayada Y, Matsushita H, Nakamura H, Taoka T, Kohno M (2005) Relationships between echocardiographic findings, pulse wave velocity, and carotid atherosclerosis in type 2 diabetic patients. Hypertens Res 28(12):965–971
35. Yambe M, Tomiyama H, Hirayama Y, Gulniza Z, Takata Y, Koji Y, Motobe K, Yamashina A (2004) Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res 27(9):625–631
36. Okamoto Y, Fujita SI, Morita H, Kizawa S, Ito T, Sakane K, Sohmiya K, Hoshiga M, Ishizaka N (2014) Association between circulating FGF23, alpha-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction. Heart Vessels. doi:10.1007/s00380-014-0581-9
37. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124(23):2491–2501
38. Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidity drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263–271
39. Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, Doring A, Broeckel U, Riegger G, Schunkert H (2003) Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24(4):320–328
40. Allison MA, Wright CM (2005) Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1). Int J Cardiol 98(2):325–330
41. Udelson JE (2011) Heart failure with preserved ejection fraction. Circulation 124(21):e540–e543
42. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ (1998) Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339(27):1972–1978
43. Thurmann PA, Kenedi P, Schmidt A, Harder S, Rietbrock N (1998) Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. Circulation 98(19):2037–2042
44. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH (2003) Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108(15):1831–1838